For All Parents and Guardians.

The 2023-2024 formulation of the COVID vaccine is here!

We will be providing the COVID vaccine to children 6 months and older.

On September 11, 2023, the U.S. Food and Drug Administration approved or authorizing for emergency use updated COVID-19 vaccines to provide better protection against serious consequences of COVID-19, including hospitalization and death.

• These actions relate to updated mRNA vaccines for 2023-2024 manufactured by ModernaTX Inc. and Pfizer, updated to include a monovalent (single) component that corresponds to the Omicron variant XBB.1.5.
• Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula): individuals ages 6 months and older.
• Moderna COVID-19 Vaccine (2023-2024 Formula): individuals ages 6 months and older.
• FDA has not yet authorized or approved a Novavax vaccine for 2023-2024. As a result, the existing Novavax vaccine may still be administered at this time if it is determined that the individual should not wait for a 2023-2024 Novavax COVID-19 vaccine.

Insurance plans will cover the 2023-2024 COVID-19 vaccines immediately

• The Affordable Care Act (ACA) requires insurers to cover most ACIP-recommended vaccines without cost sharing by the next coverage year — COVID-19 vaccines are on recommended schedules since February 2023
• Section 3203 of the CARES Act expedites coverage of COVID-19 vaccines beyond that which is required of most preventive services — As of January 5, 2021: “plans and issuers must cover COVID-19 vaccines and their administration without cost sharing immediately once the vaccine becomes authorized under an EUA or approved under a BLA, and according to the scope of the applicable EUA or BLA
• InJuly 2023, HHS issued guidance to payors to prepare to cover COVID-19 vaccination with the onset of COVID-19 vaccine commercialization

People with Medicare and Medicaid will also have access to COVID-19 vaccines at no cost

• COVID-19 vaccines covered under Medicare Part B without cost-sharing
• Inflation Reduction Act, passed in August 2022, includes key provisions: — Eliminates cost-sharing for all ACIP-recommended vaccines under Medicaid and Medicare Part D/equivalent plans — Guarantees that nearly 5o million Medicare beneficiaries and more than 8o million Medicaid beneficiaries will have access to all vaccines recommended by ACIP without cost-sharing NMDOH

VFC Program Eligibility

The Vaccines for Children (VFC) program is a federally-funded program that provides vaccines at no cost to children who might not otherwise be vaccinated because of an inability to pay. It is based on an unprecedented approach to improving vaccine availability nationwide - making federally purchased vaccine available to both public and private immunization providers.

VFC covers vaccines recommended by the Advisory Committee on Immunization Practices (ACIP). Medicaid-eligible children and those providers who provide care to the Medicaid population (i.e., Medicaid providers) represent the majority of VFC federal vaccine-eligible children and VFC providers. It also includes other VFC program-enrolled providers and the other VFC-eligible children who qualify.

The VFC program covers Children 0 through 18 years of age who meet at least one of the criteria:

• Medicaid eligible
• Uninsured, or
• American Indian/Alaska Native, or
• Underinsured

ACIP Endorses FDA Approval and Authorization

• Children 6 months to 4 years who were previously unvaccinated are recommended to get either 2 doses of Moderna, or 3 doses of Pfizer.
• ACIP supported this universal recommendation based on the totality of evidence for long COVID, severe disease in healthy adults/children, etc.

You may register directly by emailing us This email address is being protected from spambots. You need JavaScript enabled to view it..

Please include your full name, date of birth, and patient name if you are making an appointment for your child. You may also text us the information: (877) 733-6131